262 related articles for article (PubMed ID: 21723878)
1. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
Lane J; O'Leary MA; Isbister GK
Toxicon; 2011 Sep; 58(3):239-46. PubMed ID: 21723878
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation.
Ramasamy S; Isbister GK; Hodgson WC
Toxicon; 2004 Dec; 44(8):837-45. PubMed ID: 15530965
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxic effects of venoms from seven species of Australasian black snakes (Pseudechis): efficacy of black and tiger snake antivenoms.
Ramasamy S; Fry BG; Hodgson WC
Clin Exp Pharmacol Physiol; 2005; 32(1-2):7-12. PubMed ID: 15730427
[TBL] [Abstract][Full Text] [Related]
4. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?
O'Leary MA; Schneider JJ; Krishnan BP; Lavis C; McKendry A; Ong LK; Isbister GK
Toxicon; 2007 Aug; 50(2):206-13. PubMed ID: 17467763
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
[TBL] [Abstract][Full Text] [Related]
6. Cross-neutralisation of the neurotoxic effects of Egyptian cobra venom with commercial tiger snake antivenom.
Kornhauser R; Isbister GK; O'Leary MA; Mirtschin P; Dunstan N; Hodgson WC
Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):138-43. PubMed ID: 22788931
[TBL] [Abstract][Full Text] [Related]
7. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
8. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
[TBL] [Abstract][Full Text] [Related]
9. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum.
Kulawickrama S; O'Leary MA; Hodgson WC; Brown SG; Jacoby T; Davern K; Isbister GK
Toxicon; 2010 Jul; 55(8):1510-8. PubMed ID: 20223258
[TBL] [Abstract][Full Text] [Related]
10. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
O'Leary MA; Isbister GK
Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
[TBL] [Abstract][Full Text] [Related]
11. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms.
Chetty N; Du A; Hodgson WC; Winkel K; Fry BG
Toxicon; 2004 Aug; 44(2):193-200. PubMed ID: 15246769
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant activity of black snake (Elapidae: Pseudechis) venoms: Mechanisms, potency, and antivenom efficacy.
Zdenek CN; Youngman NJ; Hay C; Dobson J; Dunstan N; Allen L; Milanovic L; Fry BG
Toxicol Lett; 2020 May; 330():176-184. PubMed ID: 32442717
[TBL] [Abstract][Full Text] [Related]
15. Severe rhabdomyolysis from red-bellied black snake (Pseudechis porphyriacus) envenoming despite antivenom.
Lim AY; Singh PN; Isbister GK
Toxicon; 2016 Jul; 117():46-8. PubMed ID: 27039255
[TBL] [Abstract][Full Text] [Related]
16. The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms.
Chowdhury A; Youngman NJ; Liu J; Lewin MR; Carter RW; Fry BG
Toxicol Lett; 2022 Aug; 366():26-32. PubMed ID: 35788045
[TBL] [Abstract][Full Text] [Related]
17. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
[TBL] [Abstract][Full Text] [Related]
18. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
[TBL] [Abstract][Full Text] [Related]
19. Revisiting Notechis scutatus venom: on shotgun proteomics and neutralization by the "bivalent" Sea Snake Antivenom.
Tan CH; Tan KY; Tan NH
J Proteomics; 2016 Jul; 144():33-8. PubMed ID: 27282922
[TBL] [Abstract][Full Text] [Related]
20. Toxinology of venoms from five Australian lesser known elapid snakes.
Pycroft K; Fry BG; Isbister GK; Kuruppu S; Lawrence J; Ian Smith A; Hodgson WC
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):268-74. PubMed ID: 22682331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
